Contents:

Title Index Table of Contents 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Study Reliability and Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions and Scope of Study - Cell/Tissue Culture Media, Sera and Reagents 2. MARKET DYNAMICS - Outlook - Biopharmaceutical Drugs Fuel Cell Culture Market - Market Scenario - Industrial vs. Academic - Biotechnology Sector - Affected by Collapse of Capital Market - Global Market Analysis - Market Structure 3. TRENDS AND ISSUES - US Government’s Policies to Boost Cell Culture Market - Surging Demand for Cell Culture Products - Stem Cells and Vaccines - Key Drivers - Growing Acceptance for Hi-Veg Culture Media - Fed-Batch Cultures - a Big Hit with Large-Scale Bioprocessors - Changing Trend Towards Serum-Free Media - Proteomics and Pharmacokinetics to Drive Market Growth - Bioresearch and Cell Culture in Protein-Based Drug Development - CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture - Sluggish Fetal Bovine Serum Market - Specialty Media Demand on Rise - Emerging Alternatives to Conventional Serum Supplemented Media - Growth of Defined Media - Regulations Prompt Change in Trends - Media Optimization - Cell-Line Engineering Vs. Cell Culture Media - Other Trends - Underlying Threat to Cell Culture Industry - Manufacture-on-Demand: Gaining Momentum - Move Towards Contract Manufacturing - Factors Impacting Growth - Business Models Driving the Need for Contract Manufacturing - Trends in Contract Manufacturing - Target Sectors for Contract Manufacturers 4. END-USE ANALYSIS - End-Use Applications - Cell Therapy - Growing by Leaps and Bounds - Cell Therapy Applications - Key Factors Affecting the Cell Therapy Market - Future Trends - Related Market Sectors - Progenitor Cell Therapy - Stem Cell Therapy - Other Related Technologies - Somatic Cell Nuclear Transfer (SCNT) - Tissue Engineering - End Use Industries 5. CELL/TISSUE CULTURE: PHYSIOLOGICAL OVERVIEW - Introduction - History - Plant Cell and Tissue Culture (PCTC) - Cell/Tissue Culture Media, Sera and Reagents - Classical Media - Specialty Media - Serum - Fetal Bovine Serum - Serum-Free Media - Cell Culture Reagents - Role of Tissue Culture in the Growth of Cell Types - Equipment - Storage and Preservation - Maintenance - Growth Pattern - Harvesting - Media and Growth Requirements - Physiological Parameters - Medium Requirements (Often Empirical) - Feeding - Safety Precautions - Methods of Tissue Culture - Preparation of Media - Growth and Morphology - Sub Culturing Adherent Cells - Thawing Frozen Cells - Freezing Cells 6. REGULATORY ENVIRONMENT 7. PRODUCT INNOVATIONS/INTRODUCTIONS - StemCells Introduces GS1-R™ - Kollodis BioSciences Introduces Cell-Culture Reagents - The Automation Partnership Launches Automated Cell-Culture - Novartis Receives Approval to Release its New Vaccine - Invitrogen Introduces GIBCO® OpTmizer TM T-cell Expansion SFM - Lonza Develops One-Step Program - Millipore Unveils ESGRO CompleteTM PLUS Medium - Millipore Introduces Hanging Millicell® Cell Culture Inserts - SAFC Biosciences® Launches EX-CELLTM EBx® - SAFC Biosciences® Rolls Out EX-Fusion and CHO Library - Millipore Launches Epidermal Keratinocyte 3D Medium - Invitrogen Rolls Out PD-Direct® Bioprocess Services - Millipore Unveils a New Variety of Primary Human Epithelial Cells - BD Biosciences Introduces BD Analysis Kit - Thermo Fisher Scientific Rolls Out Thermo Clone - Millipore Unveils High Content Analysis Kits - Millipore Rolls Out FlowCellect™ - Invitrogen Introduces GIBCO® Bottles - Invitrogen Unveils ST SFM, STEO and STEA Differentiation Kits - Invitrogen Introduces Specific SFM for the Mesenchymal Stem Cells - StemCell Launches Cryopreservation Medium Free from Serum - Invitrogen Unveils SequalPrep™ System - Invitrogen Introduces Animal Source-Free Substrate - Invitrogen Introduces GIBCO® FoamAway™ Reagent - Genetix Develops New CytoGenetix Reagents and Kits 8. PRODUCT INTRODUCTIONS/INNOVATIONS IN THE RECENT PAST - A PERSPECTIVE BUILDER - Genetix Expands CloneMedia Semi-Solid Media Products - Invitrogen Launches STEMPRO® EZPassage™ Tool - Sigma-Aldrich Introduces GenomePlex Tissue WGA Kit - SAFC Biosciences Launches LONG®R3IGF-I in Liquid Form - Invitrogen and Novocell Introduce Media for hESC Growth - Invitrogen Releases New Culture System - Invitrogen Introduces New Line of Engineered Stem Cells - BD Biosciences Partners with StemCell Technologies - Millipore Launches MEL Cell Lines - Irvine Scientific Expands Industrial Cell Culture Product Line - Biovest International Introduces Automated Cell Culture Device - BD Biosciences Introduces BD FACSDiva™ 6.0 Software - Millipore Unveils Nylon Net Steriflip® Filter Unit - Lonza Expands Product-Portfolio with Serum Free Media - Invitrogen Launches CytoGenie™ Cytometry Software Tool - Novozymes Releases New Cell Culture Components - The Automation Partnership Launches Advanced Plating Module - Nikon Unveils BioStation CT - Corning Launches Innovative Cell Culture Solutions - GroPep Introduces New Assay Kit for Cell Culture Business - HyClone Introduces HyQ®CDM4MAb™ for Hybridoma Cell Lines - Biocrystal Presents Opticell - TAP Unveils CompacT SelecT™ - Cell Culture Technologies Develops Fortified Production Media 9. RECENT INDUSTRY ACTIVITY - Akron Biotechnology Merges with AppliChem - ChanTest Takes Over Applied Cell Sciences - Millipore to Takeover Guava Technologies - Millipore Acquires EpiTagTM Technology from Epitome Biosystems - MediCult’s BlastAssist® Culture Media Obtains FDA Approval - Capsant Signs Commercialization Agreement with VistaGen - Millipore Inks Distribution Agreement with Solabia - BD Biosciences to Establish New Production Facility - Lonza Group Takes Over amaxa - Millipore and Bayer Healthcare Sign Agreement - Applied Biosystems and Invitrogen Merge - SAFC BiosciencesTM and Celltrion Enter into Agreement - Tata Chemicals to Acquire Stake in Joil - Sartorius Stedim Biotech Acquires Wave Biotech - Sigma-Aldrich and AlphaGenix Sign Distribution Agreement - Induce Biologics and Therapure Biopharma Enter into Collaboration - International Stem Cell and Millipore Sign Distribution Agreement - Lonza Signs Agreement with Crucell 10. STRATEGIC CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER - SAFC to Increase Fermentation Capabilities of High-Potency API - Biogen Offers Contract to Jacobs Engineering Group - New Brunswick Scientific Merges with Eppendorf Group - Vitrolife Extends Agreement with Cellartis - Sigma-Aldrich Inks Distribution Agreement with CellPath - Lonza Acquires two Subsidiaries of Cambrex Bio-Businesses - Vikdas to Build Biotechnological Laboratory - Novartis to Invest in a New Cell Culture Plant in Singapore - Invitrogen Signs Agreement with Biocon - Thermo Fisher to Extend Manufacturing Operations - BD Biosciences Announces Treyburn Expansion Plans - Invitrogen and RXi Pharmaceuticals Enter into Collaboration - Millipore Forms a Strategic Alliance with Novozymes - Thermo Fisher Takes Over OptiCell Product Line - VWR Signs Agreement to Distribute Biovest’s Cell Culture Device - Genentech Constructs New Cell Culture Plant - MediCult Purchases Humagen Fertility - Millipore Acquires Serologicals - ReNeuron Inks Collaboration Agreement with CellSeed - Trans Valley Launches Tissue Cultured Variety of Mushrooms - Teva Signs Collaboration Agreement with Protalix Biotherapeutics 11. FOCUS ON SELECT MAJOR PLAYERS - Affymetrix, Inc. (USA) - AMRESCO, Inc. (USA) - BD Biosciences (USA) - Cell Culture Technologies, LLC (Switzerland) - Cell Essentials, Inc. (USA) - Irvine Scientific (USA) - Life Technologies Corporation (USA) - Lonza Biologics Plc (UK) - Mediatech, Inc. (USA) - Millipore Corporation (USA) - Medi-Cult A/S (Denmark) - MP Biomedicals (USA) - PerBio Science AB (Sweden) - PromoCell GmbH (Germany) - Sera Laboratories International (UK) - Sigma-Aldrich Corporation (USA) - SAFC Biosciences (USA) - Vitrolife AB (Sweden) 12. GLOBAL MARKET PERSPECTIVE Table 1: World Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 2: World Historic Review for Cell/Tissue Culture Supplies by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 3: World 11-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) Cell/Tissue Culture Supplies Market by Product Segment 87 Table 4: World Recent Past, Current & Future Analysis for Media Cell/Tissue Culture Supplies by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 5: World Historic Review for Media Cell/Tissue Culture Supplies by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 6: World 11-Year Perspective for Media Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) Table 7: World Recent Past, Current & Future Analysis for Sera Cell/Tissue Culture Supplies by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 8: World Historic Review for Sera Cell/Tissue Culture Supplies by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 9: World 11-Year Perspective for Sera Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years2005, 2010 & 2015 (includes corresponding Graph/Chart) Table 10: World Recent Past, Current & Future Analysis for Reagent Cell/Tissue Culture Supplies by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 11: World Historic Review for Reagent Cell/Tissue Culture Supplies by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 12: World 11-Year Perspective for Reagent Cell/ Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years2005, 2010 & 2015 (includes corresponding Graph/Chart) 13. THE UNITED STATES A.Market Analysis Current & Future Analysis Cell & Tissue Culture Market A Brief Insight Market Trends Trend Towards Serum-Free Media Liquid and Powdered Media Account for Major Share Table 13: Leading Players in the US Cell Culture Media Market (2008): Percentage Breakdown of Sales for - Sigma-Aldrich, Hyclone, Lonza Biologics, and Others (includes corresponding Graph/Chart) Fetal Bovine Serum - On A Decline Rise in Cell Culture Equipment Demand Leads to Innovation Market for Stem Cell Research End-Use Analysis Table 14: US Market for Cell Culture Reagents by End Use - Academic, Industrial, and Non-Academic (2008) (includes corresponding Graph/Chart) Factors Influencing the Market for Tissue and Cell Culture Media Regulatory Controls Guidelines Governing Use of Cell/Tissue Culture Reagents MSDS and Hazardous Information Toxic Substances Control Act B.Market Analytics Table 15: US Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 16: US Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 17: US 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 14. CANADA A.Market Analysis Current & Future Analysis Biotechnology Industry B.Market Analytics Table 18: Canadian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 19: Canadian Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 20: Canadian 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 15. JAPAN A.Market Analysis Current & Future Analysis B.Market Analytics Table 21: Japanese Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 22: Japanese Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 23: Japanese 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 16. EUROPE A.Market Analysis Current & Future Analysis Market Overview B.Market Analytics Table 24: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Geographic Region - France, Germany, UK, Italy & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 25: European Historic Review for Cell/Tissue Culture Supplies by Geographic Region - France, Germany, UK, Italy and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 26: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 27: European Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 28: European 11-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy & Rest of Europe Markets for Years2005, 2010 & 2015 (includes corresponding Graph/Chart) Table 29: European 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 16a. FRANCE Market Analysis Current & Future Analysis Table 30: French Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 31: French Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 32: French 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 16b. GERMANY A.Market Analysis Current & Future Analysis Biotech Research Scenario Table 33: German Biotech Market (2009): Percentage Breakdown by Application Area - Environment, Human Health Care, Chemical industry, Food, Agriculture, Energy, and Others (includes corresponding Graph/Chart) B.Market Analytics Table 34: German Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 35: German Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 36: German 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years2005, 2010 & 2015 (includes corresponding Graph/Chart) 16c. ITALY Market Analysis Current & Future Analysis Table 37: Italian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 38: Italian Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 39: Italian 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 16d. THE UNITED KINGDOM A.Market Analysis Current & Future Analysis Biotechnology Industry - A Brief Insight Regulatory Issues HFE Act Guidelines The Ethical Issues B.Market Analytics Table 40: UK Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 41: UK Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) (includes corresponding Graph/Chart) Table 42: UK 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 16e. REST OF EUROPE A.Market Analysis Current & Future Analysis Scenario in other European Countries B.Market Analytics Table 43: Rest of Europe Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 44: Rest of Europe Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 45: Rest of Europe 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 17. ASIA-PACIFIC A.Market Analysis Current & Future Analysis Rise of Cell Culture in Asia India Cell Culture Market Constituents China Taiwan Australia B.Market Analytics Table 46: Asia-Pacific Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 47: Asia-Pacific Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 48: Asia-Pacific 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 18. LATIN AMERICA A.Market Analysis Current & Future Analysis Brazilian Biotech Industry B.Market Analytics Table 49: Latin American Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) Table 50: Latin American Historic Review for Cell/Tissue Culture Supplies by Product Segment - Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) Table 51: Latin American 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment - Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) COMPETITION Total Companies Profiled: 131 (including Divisions/Subsidiaries - 151) --------- Region/Country Players --------- The United States 89 Canada 4 Japan 2 Europe 45 France 2 Germany 10 The United Kingdom 19 Spain 1 Rest of Europe 13 Asia-Pacific (Excluding Japan) 7 Latin America 1 Middle East 3 ---------

Companies Mentioned

The Companies Mentioned inside the report include: Aastrom Biosciences Inc (USA) ABgene (United Kingdom) Advanced Biotechnologies, Inc (USA) American Type Culture Collection (USA) Amphioxus Cell Technologies, Inc (USA) Amresco, Inc (USA) Analytical Biological Services, Inc (USA) Barnstead International (USA) Becton, Dickinson & Company (USA) BD Biosciences (USA) Bellco Glass Inc (USA) Bibby Sterilin Limited (United Kingdom) Biochrom AG (Germany) Biocientifica SA (Argentina) Biocrystal, Ltd (USA) Biodesign Inc (USA) Biohit PLC (Finland) Biological Industries (Israel) Biomedical Technologies, Inc (USA) Bio-Rad Laboratories, Inc (USA) BioReliance Corporation (USA) BioSource Europe SA (Belgium) Biosource International, Inc (USA) Biofluids Biotage, Inc (USA) Biowest (France) Boston Scientific Corporation (USA) BrandTech Scientific, Inc (USA) CalbaTech, Inc (USA) Cambrex Bio Science Walkersville, Inc (USA) Cell Applications, Inc (USA) Cell Culture Technologies (Switzerland) Cell Essentials, Inc (USA) Cell Sciences, Inc (USA) Cellontech Co, Ltd (Korea) CellzDirect, Inc (USA) Centerchem, Inc (USA) Clinical Cell Culture Ltd (United Kingdom) Cole-Parmer Instrument Company (USA) Commonwealth Biotechnologies, Inc (USA) Conception Technologies (USA) Corning, Inc (USA) Coy Laboratory Products, Inc (USA) CSL Biosciences (Australia) Digene Corporation (USA) Don Whitley Scientific Ltd (UK) Drummond Scientific Co (USA) Eberbach Corporation (USA) Essen Instruments, Inc (USA) Fertipro NV (Belgium) Gemini Bio-Products (USA) Genzyme Corporation (USA) Globepharm Ltd (UK) Greiner Bio-One GmbH (Germany) Grupo Grifols (Spain) Harvard Bioscience, Inc (USA) Hyclone Laboratories, Inc (USA) Imgenex Corporation (USA) Instruchemie BV (Netherlands) Integra Biosciences GmbH (Germany) Invitrogen Corporation (USA) Irvine Scientific, Inc (USA) JRH Biosciences, Inc (USA) Kemp Biotechnologies (USA) Kimble/Kontes Glass, Inc (USA) Leica Microsystems, Inc (USA) Mandel Scientific Company, Inc (Canada) Mediatech, Inc (USA) Medi-Cult A/S (Denmark) Midwest Scientific (USA) Millenium Biologix Corporation (Canada) Millipore Corporation (USA) Minerva Biolabs GmbH (Germany) Molecular Research Center, Inc (USA) MP Biomedicals, Inc (USA) Nalge Nunc International, Inc (USA) New Brunswick Scientific Co, Inc (USA) Osiris Therapeutics, Inc (USA) Pall Corporation (USA) Para Scientific Co (USA) PerBio Science AB (Sweden) Plas-Labs, Inc, (USA) Pope Scientific, Inc (USA) Preiser Scientific Inc (USA) Promocell GmbH (Germany) Protide Pharmaceuticals Inc (USA) Quality Biological, Inc (USA) R&D Systems, Inc (USA) Research Organics, Inc (USA) Roche Molecular Biochemicals (USA) Sartorius BBI Systems GMBH (Germany) Sartorius BBI Systems Inc (USA) Scientific Industries, Inc (USA) Sentigen Holding Corporation (USA) Sentigen Biosciences (USA) Cell and Molecular Technologies Inc (USA) Sera Laboratories International Ltd (UK) Serologicals Corporation (USA) Celliance Corporation (USA) Chemicon International, Inc (USA) Serotec Ltd (UK) Sigma-Aldrich Corporation (USA) Sigma-Aldrich Co, Ltd (UK) Spectrocell (USA) Spectrum Laboratory Products, Inc (USA) Stratagene, Inc (USA) SurModics, Inc (USA) Techne, Inc (USA) The Binding Site Ltd (United Kingdom) Theratechnologies (Canada) Thermo Electron Corporation (USA) Thomas Scientific (USA) USA Scientific, Inc (USA) USB Corporation (USA) Vitrolife AB (Sweden) Vivascience AG (Germany) Wave Biotech LLC (USA) Whatman PLC (UK) Wheaton Science Products (USA) Wilmad-Labglass (USA) Wisent, Inc (Canada)